Want to take quizzes and track your credits?
In December 2019 in Wuhan, China, a novel coronavirus, designated as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), caused an international outbreak of respiratory illness termed coronavirus disease 2019 (COVID-19). Common symptoms include fever, fatigue, cough, and shortness of breath.1 Although most cases result in mild symptoms, it is estimated that around 5% of patients develop severe pneumonia and multiorgan failure.2 A recent Italian study3 reported a spectrum of cutaneous eruptions with nonspecific features in more than 20% of a small cohort of patients with COVID-19. We report a case of a digitate papulosquamous eruption occurring during a SARS-CoV-2 infection.
Sign in to take quiz and track your certificates
JN Learning™ is the home for CME and MOC from the JAMA Network. Search by specialty or US state and earn AMA PRA Category 1 CME Credit™ from articles, audio, Clinical Challenges and more. Learn more about CME/MOC
Corresponding Author: Bethsabée Garel, MD, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris, Division of Dermatology and Venereology, Pavillon Tarnier, 89 rue d’Assas, 75006 Paris, France (firstname.lastname@example.org).
Published Online: April 30, 2020. doi:10.1001/jamadermatol.2020.1704
Conflict of Interest Disclosures: None reported.
You currently have no searches saved.